Research Site

Sun City, Arizona 85704

1 studies enrolling now · 11 studies all time

What they study most

Alzheimer's Disease, Dementia With Lewy Bodies, Eosinophilic Asthma, Lewy Body Parkinson's Disease, Mild Cognitive Impairment, Parkinson's Disease, Primary Parkinsonism, Progressive Cognitive Decline, Relapsing-Remitting Multiple Sclerosis, Rheumatoid Arthritis, Supranuclear Palsy, Progressive

Studies at this site

• Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment — Recruiting now
• Autopsy Follow-up of Subjects Previously Imaged With Florbetapir F 18 (18F-AV-45) PET in Trial 18F-AV-45-A07 — Completed
• A Study to Evaluate the Safety and Efficacy of VIB4920 in Participants With Rheumatoid Arthritis — Completed
• Study of BIIB092 in Participants With Progressive Supranuclear Palsy — Stopped early
• Observational Study of Tysabri in Early Relapsing-Remitting Multiple Sclerosis in Anti-JC Virus Antibody Negative Participants — Completed
• A Trial of 18F-AV-133 Positron Emission Tomography (PET) Imaging to Differentiate Subjects With Parkinson's Disease (PD) From Other Movement Disorders — Completed
• Effectiveness of Florbetapir (18F) PET Imaging in Changing Patient Management and the Relationship Between Scan Status and Cognitive Decline — Completed
• Potential of Florbetapir F 18 PET to Inform Clinical Diagnosis and Management of Patients With Progressive Cognitive Decline — Completed
• A Trial of 18F-AV-133 and 18F-AV-45 Positron Emission Tomography (PET) — Completed
• Phase III Study of the Correlation Between Florbetapir F18 PET Imaging and Amyloid Pathology in the Brain — Completed
• A Phase II Trial of 18F-AV-45 Positron Emission Tomography (PET) Imaging in Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD) — Completed